Ophthalmological manifestations in segmental neurofibromatosis type 1

British Journal of Ophthalmology

Volumn 88, Issue 11, 2004, Pages 1429-1433

  Ruggieri, Martino ^a,b   Pavone, P ^b   Polizzi, A ^b   Di Pietro, M ^b   Scuderi, A ^b   Gabriele, A ^c   Spalice, A ^b   Iannetti, P ^d  

^a INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c CNR   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANTERIOR EYE SEGMENT; ARTICLE; CAFE AU LAIT SPOT; CELL CLONE; CHILD; COLOR VISION TEST; DNA DETERMINATION; EYE DISEASE; FEMALE; GENE; GENE MUTATION; HUMAN; HYPERTELORISM; INFANT; ITALY; LENTIGO; MAJOR CLINICAL STUDY; MALE; MOSAICISM; NEUROFIBROMATOSIS; NF1 GENE; OPHTHALMOSCOPY; OPTIC NERVE GLIOMA; PRIORITY JOURNAL; RETINA EXAMINATION; SLIT LAMP; VISUAL ACUITY; VISUAL FIELD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; EYE DISEASES; FEMALE; GLIOMA; HUMANS; INFANT; MALE; MIDDLE AGED; NEUROFIBROMATOSIS 1; OPTIC NERVE NEOPLASMS; PIGMENTATION DISORDERS; VISUAL ACUITY;

EID: 7044239075     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2004.043802     Document Type: Article

References (40)

1. Happle RH. A rule concerning the segmental manifestation of autosomal dominant skin disorders. Review of clinical examples providing evidence for dichotomous types of severity. Arch Dermatol 1997;133:1505-9.
2. Zlotogora J. Germ line mosaicism. Hum Genet 1998;102:381-6.
3. Itin PH, Buechner SA. Segmental forms of autosomal dominant skin disorders: the puzzle of mosaicism. Am J Med Genet 1999;86:351-4.
4. Rott HD. Extracutaneous anomalies of Blaschko lines. Am J Med Genet 1999;85:338-41.
5. Moss C, Green SH. What is segmental neurofibromatosis ? Br J Dermatol 1994;130:106-10.
6. Huson SM, Ruggieri M. The neurofibromatoses. In: Harper J, Oranje JM, Rose M, eds. Textbook of pediatric dermatology. Vol II. Oxford: Blackwell Science, 2000:1204-24.
7. Mac Collin M, Woodfin W, Kronn D, et al. Schwannomatosis: a clinical and pathologic study. Neurology 1996;46:1072-9.
8. Antinheimo J, Sankila R, Carpèn O, et al. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and Schwannomas. Neurology 2000;54:71-6.
9. Ingordo V, D'Andria G, Mendicini S, et al. Segmental neurofibromatosis: is it uncommon or underdiagnosed ? Arch Dermatol 1995;131:959-60.
10. Wolkenstein P, Mahmoudi A, Zeller J, et al. More on the frequency of segmental neurofibromatosis. Arch Dermatol 1995;131:1465.
11. Hager CM, Cohen PR, Tschen JA. Segmental neurofibromatosis: case report and review. J Am Acad Dermatol 1997;37:864-9.
12. Wallace M, Bauer M, Rasmussen S, et al. Segmental and mosaic forms of neurofibromatosis 1: molecular and embryological insights. Am J Hum Genet. 1997;61: A412 (Abstract)).
13. Hix K, Rothner D, Cohen B. Segmental neurofibromatosis: analysis of 14 cases. Ann Neurol. 1998;44:575-6 (Abstract)).
14. Ruggieri M, Huson SM. The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology 2001;56:1434-43.
15. Gutman DH, Aynsworth A, Carey JC, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997;278:51-7.
16. Friedman J, Gutman DH, MacCollin M, et al. In: Neurofibromatosis: phenotype, natural history and pathogenesis, 3rd ed. Baltimore: Johns Hopkins University Press, 1999.
17. Tinschert S, Naumann I, Stegmann E, et al. Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene. Eur J Hum Genet 2000;8:455-9.
18. Vandenbroucke I, Van Doom R, Callens T, et al. Genetic and clinical mosaicism in a patient with neurofibromatosis type 1. Hum Genet 2004;114:284-90.
19. MacCollin M, Jacoby LB, Jones D, et al. Somatic mosaicism of the neurofibromatosis type 2 suppressor-gene. Neurology 1997;48:A429.
20. Viskochil D, Carey JC. Alternate forms of NF1 and NF2. In: Huson SM, Hughes RAC, eds. The neurofibromatoses: a clinical and pathogenetic overview. London: Chapman and Hall, 1994:455-74.
21. NIH Consensus Development Conference Statement. Neurofibromatosis. Arch Neurol 1988;45:575-8.
22. Wolkenstein P, Freche B, Zeller J, et al. Usefulness of screening investigations in neurofibromatosis type 1. A study of 152 patients. Arch Dermatol 1996;132:1333-6.
23. Ruggieri M. The different forms of neurofibromatosis. Child's Nerv Syst 1999;15:295-308.
24. Ruggieri M. Mosaic (segmental) neurofibromatosis type 1 (NF1) and type 2 (NF2): no longer neurofibromatosis type 5 (NF5). Am J Med Genet 2001;101:178-80.
25. Riccardi VM, Lewis RA. Penetrance of von Recklingausen neurofibromatosis: a distinction between predecessors and descendants. Am J Hum Genet 1988;42:284-9.
26. Huson SM, Hughes RAC. The neurofibromatoses: pathogenic and clinical overview. London: Chapman and Hall, 1994:253-74.
27. Beauchamp G. Neurofibromatosis type 1 in children. Trans Am Ophthal Soc 1995;93:445-72.
28. Listernick R, Mancini AJ, Charrow J. Segmental neurofibromatosis in childhood. Am J Med Genet 2003;121A:132-5.
29. Blakley P, Louis DN, Short MP, et al. A clinical study of patients with multiple isolated neurofibromas. J Med Genet 2001;38:485-8.
30. MacCollin M, Willett C, Heinrich B, et al. Familial schwannomatosis: exclusion of the NF2 locus as the germline event. Neurology 2003;60:1968-74.
31. Leverkus M, Kluwe L, Roll EM, et al. Multiple unilateral schwannomas: segmental neurofibromatosis type 2 or Schwannomatosis? Br J Dermatol 2003;148:804-9.
32. Brudler CE, Ichimura K, Tingby O, et al. A group of schwannomas with interstitial deletions on 22 located outside the NF2 locus show no detectable mutations in the NF2 gene. Hum Genet 1999;104:418-24.
33. Kauffman DL, Heinrich BS, Willett C, et al. Somatic instability of the NF2 gene in schwannomatosis. Arch Neurol 2003;60:1317-20.
34. Riccardi VM. Neurofibromatosis: clinical heterogeneity. Curr Probl Cancer 1982;7:1-34.
35. Rubenstein A, Bader JL, Aron AA, et al. Familial transmission of segmental neurofibromatosis. Neurology. 1983;33:76 (Abstract), (S2).
36. Boltshauser E, Stocker H, Machler M. Neurofibromatosis type 1 in a child of a parent with segmental neurofibromatosis (NF-5). Neurofibromatosis 1989;2:244-5.
37. Uhlin SR. Segmental neurofibromatosis. South Med J 1980;73:526-7.
38. Segal R. Segmental neurofibromatosis of the sciatic nerve: case report. Neurosurgery 1993;33:948.
39. Lazaro C, Ravella A, Gaona A, et al. Neurofibromatosis type 1 due to germ-line mosaicism in a clinically normal father. N Engl J Med 1994;331:1403-7.
40. Gardner RL. Cell lineage and cell commitment in the early mammalian embryo. In: Warshaw JB, eds. The biological basis of reproductive and developmental medicine. Amsterdm: Elsevier, 1983:31-41.